AZD8848
Sponsors
AstraZeneca
Conditions
Allergic AsthmaAllergic RhinitisButyrylcholinesterase DeficiencyHealthyHealthy SubjectsHealthy VolunteersSafety,Tolerability,
Phase 1
Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
CompletedNCT00688779
Start: 2008-01-31End: 2009-04-30Updated: 2015-08-14
Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848
CompletedNCT00770003
Start: 2008-09-30End: 2010-02-28Updated: 2015-08-14
A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers
CompletedNCT01203124
Start: 2010-11-30End: 2012-02-29Updated: 2015-08-14
Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
CompletedNCT01205867
Start: 2010-09-30End: 2012-01-31Updated: 2015-08-14
AZD8848 Single Ascending Dose Study
CompletedNCT01560234
Start: 2012-05-31End: 2014-07-31Updated: 2016-06-06
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects
CompletedNCT01818869
Start: 2014-01-31End: 2014-02-28Updated: 2015-08-14
Phase 2
The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen
CompletedNCT00999466
Start: 2009-10-31End: 2011-12-31Updated: 2016-02-26
Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
CompletedNCT01185080
Start: 2010-09-30End: 2012-01-31Updated: 2016-01-07